Parkside Financial Bank & Trust’s Terns Pharmaceuticals TERN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35	Closed	-$1.85K	–	2790
2026 Q1	$1.85K	Hold	35	–	–	﹤0.01%	2144
2025 Q4	$1.41K	Buy	+35	New	+$809	﹤0.01%	2219

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parkside Financial Bank & Trust's TERN Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 35 shares — an estimated $1.85K sold.

Parkside Financial Bank & Trust first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $1.85K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Parkside Financial Bank & Trust reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Parkside Financial Bank & Trust sold 35 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.85K.
Parkside Financial Bank & Trust first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Parkside Financial Bank & Trust's Terns Pharmaceuticals position peaked at $1.85K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.